Introduction To determine if gender influences clinical outcomes and durability of repair after carotid angioplasty with stenting (CAS) or carotid endartercetomy (CEA), an analysis of patient records was performed.
Methods This study included 89 CAS patients (47 men and 42 women) and 93 CEA patients (53 men and 40 women). Patients underwent duplex scans 6, 12, 24 months postprocedure. The outcomes of periprocedural mortality, major adverse events, strokes, and myocardial infarctions were assessed. Incidence of critical restenosis and recurrence of symptoms was also assessed.
Results No significant differences were noted between men and women who had undergone either CAS or CEA (P > .05) for clinical outcomes and durability of repair. No differences for periprocedural mortality, major adverse events, critical restenosis, recurrent neurologic symptoms, and adverse event free survival were found.
Conclusions These results do not indicate substantial gender influences on clinical outcomes or durability of repair following CAS and CEA.
Heart attack, stroke, and cardiac arrest warning signs. American Heart Association Web site. http://www.americanheart.org/presenter.jhtml?identifier=3053#Stroke . Accessed July 24, 2007.
2.
Welch KMMA, Caplan LR, Reis DJ, eds. Primer on Cerebrovascular Diseases. Burlington, MA: Elsevier Science and Technology Books; 1997 .
3.
Barnett HJ, Taylor DW, Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415-1425.
4.
Roubin GS, New G., Iyer SS, et al. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273: 1421-1428.
5.
European Carotid Surgery Trialists' Collaborative Group.Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
6.
Halliday A., Mansfield A., Marro J., et al. (MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group).Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-1502.
7.
Counsell C., Naylor R., Warlow C.Regarding "Prospective randomized trials of carotid endarterectomy with primary closure and patch reconstruction: the problem is power." J Vasc Surg. 1998;27:386-387.
8.
Golledge J., Mitchell A., Greenhalgh RM, Davies A.Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke. 2000;31:1439-1443.
9.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
10.
CAVATAS investigators.Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357: 1729-1737.
11.
Gray W., Hopkins N., Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR Results. J Vasc Surg. 2006;44:258-268.
12.
The SPACE Collaborative Group.30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: arandomized non-inferiority trial. Lancet. 2006;368:1239-1247.
13.
Mas JL, Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ;355:1660-1671.
14.
Akbari C., Pullings M., Pomposelli F., et al. Gender and carotid endarterectomy: Does it matter? J Vasc Surg. 2000;31:1103-1109.
15.
Mattos M., Sumner D., Bohannon T., et al. Carotid endarterectomy in women: challenging the results from ACAS and NASCET. Ann Surg. 2001;234:438-446.
16.
Sarac T., Hertzer N., Mascha E., et al. Gender as a primary predictor of outcome after carotid endarterectomy . J Vasc Surg. 2002;35:748-753.
17.
LaMuraglia G., Stoner M., Brewster D., et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg. 2005; 41:762-768.
18.
James D., Hughes J., Mills J., Westerband A.The influence of gender on complications of carotid endartectomy. Am J Surg. 2001;182:654-657.
19.
Lane J., Shekerherdimian S., Moore W.Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy? J Vasc Surg. 2003;37:568-574.
20.
Weise J., Kuschke S., Bahr M.Gender-specific risk of perioperative complications in carotid endarterectomy patients with contralateral carotid artery stenosis or occlusion. J Neurol. 2004;251:838-844.
21.
AbuRahma A. , Robinson P., Siaedy S., Khan J., Boland J.Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and PTFE: long-term follow-up. J Vasc Surg. 1998;27:222-234.
22.
Hugl B., Oldenburg A., Neuhauser B., Hakaim A.Effect of age and gender on restenosis after carotid endartectomy . Ann Vasc Surg. 2006;20:602-608.
23.
Roubin G., Hobson II R. , White R.Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther. 2003 ;10:1021-1030.
24.
Why CREST?CREST Trial Investigators Web site . http://www.cresttrial.org. Accessed July 24, 2007.
25.
International Carotid Stenting Study Protocol. ICSS Trial Investigators Web site. http://www.ion.ucl.ac.uk/-cavatas_icss/index2.htm. Accessed July 24, 2007.
26.
Skelly C., Gallagher K., Fairman R., et al. Risk factors for restenosis after carotid artery angioplasty and stenting. J Vasc Surg. 2006;44:1010-1015.
27.
Mannheim D. , Weller B., Vahadim E., Karmeli R.Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study. J Vasc Surg. 2005;41:403-407.
